Pharma-Grade Synthetic Camphor Market Overview

The report is titled as ‘Pharma-Grade Synthetic Camphor Market: Opportunity Analysis and Future Assessment 2020-2028’. An overview of conceptual frameworks, analytical approaches of the pharma-grade synthetic camphor market is the main objective of the report, which further consists of the market opportunity and insights of the data involved in the making of the respective market. The pharma-grade synthetic camphor market is expected to grow with a significant rate in the near future.

The global pharma-grade synthetic camphor market in 2020 is estimated for more than US$ 167.3 Mn and expected to reach a value of US$ 236.1 Mn by 2028 with a significant CAGR of 4.4%.

Pharma-Grade Synthetic Camphor Market Dynamics

Factor like the growing demand for the private labeled topical products containing camphor is expected to boost the market growth in developed regions like North America. For instance, the demand for OTC analgesics containing pharma-grade synthetic camphor includes Walgreens Ultra Strength Muscle Rub (4% camphor), Salonpas pain relieving patch (1.2% camphor), etc. These are among private label analgesics and they do not require FDA approval and thus are gaining more popularity in the U.S. market.

Also, the rebound in global trade promoting growth for camphor exports coupled with the growing trend of self-medication amongst the patients is also responsible for fueling the demand for pharma-grade synthetic camphor in the global market, thereby propelling the market growth.

Furthermore, improving supply chain management is also providing growth opportunities for pharma-grade synthetic camphor manufacturers, as it influences high growth in emerging regions like in the Asia Pacific. For instance, Merck acquired Sigma-Aldrich in 2016. Similarly, Camphor & Allied Products Ltd., a leading Indian manufacturer of pharma grade camphor, merged their business with Oriental Aromatics Limited in 2015.

Pharma-grade synthetic camphor manufacturers also witness rising demand from topical pain management products, owing to the growth recorded in the aging population coupled with the increasing count of people suffering from chronic disease. This creates a high demand for pain management topical products, thereby boosting the market growth.

Moreover, the widespread end-users applications of products like Vicks VapoRub and the beneficial properties of pharmaceutical-grade synthetic camphor, including anti-fungal and anti-inflammatory can also be considered as the revenue-generating factors for the global pharma-grade synthetic camphor market in the projected time frame.

On the contrary, the availability of substitutes and the health risks linked with the high level of camphor are likely to hamper the demand for pharmaceutical grade synthetic camphor across the globe.

Nevertheless, the on-going research and development activities to innovate new application scope for camphor along with the mounting count of the population in emerging economies such as China, India and others is creating opportunities for growth of the global market.

Pharma-Grade Synthetic Camphor Market Segmentation

The global pharma-grade synthetic camphor market is segmented on the basis of formulation type, application, distribution channel, and by region.

By Formulation Type:

Topical

Inhalation

By Application:

Respiratory Disorder

Muscular Rheumatism

Counterirritant and Antipruritic

Others

By Distribution Channel:

Conventional B2B

Tenders

Direct Procurement

Wholesalers & Distributors

Online B2B

Internal Channel

External Channel

By Region:

North America

Europe

Asia Pacific

Latin America

Middle East

Africa

Pharma-Grade Synthetic Camphor Market Key Players

Key players operating in the global pharma-grade synthetic camphor market include Aldon Corporation, Fengchen Group Co., Ltd., Mangalam Organics Limited, Merck KGaA, Nippon Fine Chemical Co., Ltd., Oriental Aromatics Limited, Prinova Group LLC, Rochem International, Inc., Saptagir Camphor Limited, and Spectrum Chemical Mfg. Corp.

Regional Segmentation

On the basis of region, the pharma-grade synthetic camphor market is segmented into North America, Europe, Asia Pacific, Latin America, Middle East, and Africa.

MMC Overview on Pharma-Grade Synthetic Camphor Market Report

The non-identical approach of Meridian Market Consultants stands with conceptual methods backed up with the data analysis. The novel market understanding approach makes up the standard of the assessment results that give better opportunity for the customers to put their effort.

A research report on the Pharma-Grade Synthetic Camphor market by Meridian Market Consultants is an in-depth and extensive study of the market based on the necessary data crunching and statistical analysis. It provides a brief view of the dynamics flowing through the market, which includes the factors that supports market and the factors that are acting as impedance for the growth of the market.

Furthermore, the report includes the various trends and opportunities in the respective market in different regions for a better understanding of readers that helps to analyze the potential of the market.

Factors that are benchmarked while estimating the market

Various factors that are benchmarked while estimating the market growth include (but not restricted to):

•    New product designs and launches

•    Current product compliance

•    Reimbursement

•    Concerns for use of Pharma-Grade Synthetic Camphor

•    Advantage of Pharma-Grade Synthetic Camphor

Actions taken by the manufacturer and respective regulatory authorities also impact the market growth of the segment. These factors are understood at regional level and in major countries globally for providing regional insights of the product segment in the report. This helps our clients to take informed decision.

A mix of top-down and bottom-up approach is followed to arrive and validate our market value estimations. For a product segment like wherein one/two manufacturer(s) dominates the market, it’s products sales, previous growth rates and market expansion plans are considered to generate market share in the global market.

1.    Global Pharma-Grade Synthetic Camphor Market Report Overview

1.1.    Introduction

1.2.    Report Description

1.3.    Methodology

2.    Global Pharma-Grade Synthetic Camphor Market Overview

2.1.    Introduction

2.1.1.    Market Definition

2.1.2.    Market Taxonomy

2.2.    Executive Summary

2.3.    Global Pharma-Grade Synthetic Camphor Market Snapshot

2.4.    Global Pharma-Grade Synthetic Camphor Market Size and Forecast, 2020–2028

2.4.1.    Introduction

2.4.2.    Market Value Forecast and Annual Growth Rate (AGR) Comparison (2020–2028)

2.5.    Global Pharma-Grade Synthetic Camphor Market Dynamics

2.5.1.    Drivers

2.5.2.    Restraints

2.5.3.    Opportunity

2.5.4.    Trends

2.6.    Key Regulations

2.7.    Porter’s Five Forces Model

3.    Global Pharma-Grade Synthetic Camphor Market, By Formulation Type

3.1.    Introduction

3.1.1.    Annual Growth Rate Comparison, By Formulation Type

3.1.2.    BPS Analysis, By Formulation Type

3.2.    Market Revenue (US$Mn) Forecast, By Formulation Type

3.2.1.    Topical

3.2.2.    Inhalation

3.3.    Global Pharma-Grade Synthetic Camphor Market Attractiveness Index, By Formulation Type

4.    Global Pharma-Grade Synthetic Camphor Market, By Application

4.1.    Introduction

4.1.1.    Annual Growth Rate Comparison, By Application

4.1.2.    BPS Analysis, By Application

4.2.    Market Revenue (US$Mn) Forecast, By Application

4.2.1.    Respiratory Disorder

4.2.2.    Muscular Rheumatism

4.2.3.    Counterirritant and Antipruritic

4.2.4.    Others

4.3.    Global Pharma-Grade Synthetic Camphor Market Attractiveness Index, By Application

5.    Global Pharma-Grade Synthetic Camphor Market, By Distribution Channel

5.1.    Introduction

5.1.1.    Annual Growth Rate Comparison, By Distribution Channel

5.1.2.    BPS Analysis, By Distribution Channel

5.2.    Market Revenue (US$Mn) Forecast, By Distribution Channel

5.2.1.    Conventional B2B

5.2.1.1.     Tenders

5.2.1.2.     Direct Procurement

5.2.1.3.     Wholesalers & Distributors

5.2.2.    Online B2B

5.2.2.1.     Internal Channel

5.2.2.2.     External Channel

5.3.    Global Pharma-Grade Synthetic Camphor Market Attractiveness Index, By Distribution Channel

6.    Global Pharma-Grade Synthetic Camphor Market, By Region

6.1.    Introduction

6.1.1.    Annual Growth Rate Comparison, By Region

6.1.2.    BPS Analysis, By Region

6.2.    Market Revenue (US$Mn) Forecast, By Region

6.2.1.    North America

6.2.2.    Latin America

6.2.3.    Europe

6.2.4.    Asia Pacific

6.2.5.    Middle East

6.2.6.    Africa

6.3.    Global Pharma-Grade Synthetic Camphor Market Attractiveness Index, By Region

7.    North America Pharma-Grade Synthetic Camphor Market Analysis and Forecast, 2020–2028

7.1.    Introduction

7.1.1.    Annual Growth Rate Comparison, By Country

7.1.2.    BPS Analysis, By Country

7.2.    Market Revenue (US$Mn) Forecast, By Country

7.2.1.    U.S. Pharma-Grade Synthetic Camphor Market

7.2.2.    Canada Pharma-Grade Synthetic Camphor Market

7.3.    North America Pharma-Grade Synthetic Camphor Market, By Formulation Type

7.3.1.    Topical

7.3.2.    Inhalation

7.4.    North America Pharma-Grade Synthetic Camphor Market, By Application

7.4.1.    Respiratory Disorder

7.4.2.    Muscular Rheumatism

7.4.3.    Counterirritant and Antipruritic

7.4.4.    Others 

7.5.    North America Pharma-Grade Synthetic Camphor Market, By Distribution Channel

7.5.1.    Conventional B2B

7.5.1.1.     Tenders

7.5.1.2.     Direct Procurement

7.5.1.3.     Wholesalers & Distributors

7.5.2.    Online B2B

7.5.2.1.     Internal Channel

7.5.2.2.     External Channel

7.6.    North America Pharma-Grade Synthetic Camphor Market Attractiveness Index

7.6.1.    By Country

7.6.2.    By Distribution Channel

7.6.3.    By Application

7.6.4.    By Formulation Type

8.    Latin America Pharma-Grade Synthetic Camphor Market Analysis and Forecast, 2020–2028

8.1.    Introduction

8.1.1.    Annual Growth Rate Comparison, By Country

8.1.2.    BPS Analysis, By Country

8.2.    Market (US$Mn) Forecast, By Country

8.2.1.    Brazil Pharma-Grade Synthetic Camphor Market

8.2.2.    Mexico Pharma-Grade Synthetic Camphor Market

8.2.3.    Argentina Pharma-Grade Synthetic Camphor Market

8.2.4.    Rest Of Latin America Pharma-Grade Synthetic Camphor Market

8.3.    Latin America Pharma-Grade Synthetic Camphor Market, By Formulation Type

8.3.1.    Topical

8.3.2.    Inhalation

8.4.    Latin America Pharma-Grade Synthetic Camphor Market, By Application

8.4.1.    Respiratory Disorder

8.4.2.    Muscular Rheumatism

8.4.3.    Counterirritant and Antipruritic

8.4.4.    Others 

8.5.    Latin America Pharma-Grade Synthetic Camphor Market, By Distribution Channel

8.5.1.    Conventional B2B

8.5.1.1.     Tenders

8.5.1.2.     Direct Procurement

8.5.1.3.     Wholesalers & Distributors

8.5.2.    Online B2B

8.5.2.1.     Internal Channel

8.5.2.2.     External Channel

8.6.    Latin America Pharma-Grade Synthetic Camphor Market Attractiveness Index

8.6.1.    By Country

8.6.2.    By Distribution Channel

8.6.3.    By Application

8.6.4.    By Formulation Type

9.    Europe Pharma-Grade Synthetic Camphor Market Analysis and Forecast, 2020–2028

9.1.    Introduction

9.1.1.    Annual Growth Rate Comparison, By Country

9.1.2.    BPS Analysis, By Country

9.2.    Market (US$Mn) Forecast, By Country

9.2.1.    U.K. Pharma-Grade Synthetic Camphor Market

9.2.2.    Germany Pharma-Grade Synthetic Camphor Market

9.2.3.    Italy Pharma-Grade Synthetic Camphor Market

9.2.4.    France Pharma-Grade Synthetic Camphor Market

9.2.5.    Spain Pharma-Grade Synthetic Camphor Market

9.2.6.    Russia Pharma-Grade Synthetic Camphor Market

9.2.7.    Poland Pharma-Grade Synthetic Camphor Market

9.2.8.    BENELUX Pharma-Grade Synthetic Camphor Market

9.2.9.    NORDIC Pharma-Grade Synthetic Camphor Market

9.2.10.    Rest Of Europe Pharma-Grade Synthetic Camphor Market

9.3.    Europe Pharma-Grade Synthetic Camphor Market, By Formulation Type

9.3.1.    Topical

9.3.2.    Inhalation

9.4.    Europe Pharma-Grade Synthetic Camphor Market, By Application

9.4.1.    Respiratory Disorder

9.4.2.    Muscular Rheumatism

9.4.3.    Counterirritant and Antipruritic

9.4.4.    Others 

9.5.    Europe Pharma-Grade Synthetic Camphor Market, By Distribution Channel

9.5.1.    Conventional B2B

9.5.1.1.     Tenders

9.5.1.2.     Direct Procurement

9.5.1.3.     Wholesalers & Distributors

9.5.2.    Online B2B

9.5.2.1.     Internal Channel

9.5.2.2.     External Channel

9.6.    Europe Pharma-Grade Synthetic Camphor Market Attractiveness Index

9.6.1.    By Country

9.6.2.    By Distribution Channel

9.6.3.    By Application

9.6.4.    By Formulation Type

10.    Asia Pacific Pharma-Grade Synthetic Camphor Market Analysis and Forecast, 2020–2028

10.1.    Introduction

10.1.1.    Annual Growth Rate Comparison, By Country

10.1.2.    BPS Analysis, By Country

10.2.    Market (US$Mn) Forecast, By Country

10.2.1.    China Pharma-Grade Synthetic Camphor Market

10.2.2.    India Pharma-Grade Synthetic Camphor Market

10.2.3.    Japan Pharma-Grade Synthetic Camphor Market

10.2.4.    Australia And New Zealand Pharma-Grade Synthetic Camphor Market

10.2.5.    South Korea Pharma-Grade Synthetic Camphor Market

10.2.6.    ASEAN Pharma-Grade Synthetic Camphor Market

10.2.7.    Rest Of Asia Pacific Pharma-Grade Synthetic Camphor Market

10.3.    Asia Pacific Pharma-Grade Synthetic Camphor Market, By Formulation Type

10.3.1.    Topical

10.3.2.    Inhalation

10.4.    Asia Pacific Pharma-Grade Synthetic Camphor Market, By Application

10.4.1.    Respiratory Disorder

10.4.2.    Muscular Rheumatism

10.4.3.    Counterirritant and Antipruritic

10.4.4.    Others 

10.5.    Asia Pacific Pharma-Grade Synthetic Camphor Market, By Distribution Channel

10.5.1.    Conventional B2B

10.5.1.1.     Tenders

10.5.1.2.     Direct Procurement

10.5.1.3.     Wholesalers & Distributors

10.5.2.    Online B2B

10.5.2.1.     Internal Channel

10.5.2.2.     External Channel

10.6.    Asia Pacific Pharma-Grade Synthetic Camphor Market Attractiveness Index

10.6.1.    By Country

10.6.2.    By Distribution Channel

10.6.3.    By Application

10.6.4.    By Formulation Type

11.    Middle East Pharma-Grade Synthetic Camphor Market, By Region

11.1.    Introduction

11.1.1.    Annual Growth Rate Comparison, By Country

11.1.2.    BPS Analysis, By Country

11.2.    Market (US$Mn) Forecast, By Country

11.2.1.    GCC Countries Pharma-Grade Synthetic Camphor Market

11.2.2.    Israel Pharma-Grade Synthetic Camphor Market

11.2.3.    Oman Pharma-Grade Synthetic Camphor Market

11.2.4.    Rest Of Middle East Pharma-Grade Synthetic Camphor Market

11.3.    Middle East Pharma-Grade Synthetic Camphor Market, By Formulation Type

11.3.1.    Topical

11.3.2.    Inhalation

11.4.    Middle East Pharma-Grade Synthetic Camphor Market, By Application

11.4.1.    Respiratory Disorder

11.4.2.    Muscular Rheumatism

11.4.3.    Counterirritant and Antipruritic

11.4.4.    Others 

11.5.    Middle East Pharma-Grade Synthetic Camphor Market, By Distribution Channel

11.5.1.    Conventional B2B

11.5.1.1.     Tenders

11.5.1.2.     Direct Procurement

11.5.1.3.     Wholesalers & Distributors

11.5.2.    Online B2B

11.5.2.1.     Internal Channel

11.5.2.2.     External Channel

11.6.    Middle East Pharma-Grade Synthetic Camphor Market Attractiveness Index

11.6.1.    By Country

11.6.2.    By Distribution Channel

11.6.3.    By Application

11.6.4.    By Formulation Type

12.    Africa Pharma-Grade Synthetic Camphor Market, By Region

12.1.    Introduction

12.1.1.    Annual Growth Rate Comparison, By Country

12.1.2.    BPS Analysis, By Country

12.2.    Market (US$Mn) Forecast, By Country

12.2.1.    South Africa Pharma-Grade Synthetic Camphor Market

12.2.2.    Egypt Pharma-Grade Synthetic Camphor Market

12.2.3.    North Africa Pharma-Grade Synthetic Camphor Market

12.2.4.    Rest Of Africa Pharma-Grade Synthetic Camphor Market

12.3.    Africa Pharma-Grade Synthetic Camphor Market, By Formulation Type

12.3.1.    Topical

12.3.2.    Inhalation

12.4.    Africa Pharma-Grade Synthetic Camphor Market, By Application

12.4.1.    Respiratory Disorder

12.4.2.    Muscular Rheumatism

12.4.3.    Counterirritant and Antipruritic

12.4.4.    Others 

12.5.    Africa Pharma-Grade Synthetic Camphor Market, By Distribution Channel

12.5.1.    Conventional B2B

12.5.1.1.     Tenders

12.5.1.2.     Direct Procurement

12.5.1.3.     Wholesalers & Distributors

12.5.2.    Online B2B

12.5.2.1.     Internal Channel

12.5.2.2.     External Channel

12.6.    Africa Pharma-Grade Synthetic Camphor Market Attractiveness Index

12.6.1.    By Country

12.6.2.    By Distribution Channel

12.6.3.    By Application

12.6.4.    By Formulation Type

13.    Recommendation

13.1.    Market Strategy

14.    Competitive Landscape

14.1.    Competition Dashboard

14.2.    List and Company Overview of Global Key Players

14.3.    Company Profiles

14.3.1.    Aldon Corporation

14.3.1.1.    Company Overview

14.3.1.2.    Financial Overview

14.3.1.3.    Product Portfolio

14.3.1.4.    Key Developments

14.3.1.5.    Business Strategies

14.3.2.    Fengchen Group Co., Ltd.

14.3.3.    Mangalam Organics Limited

14.3.4.    Merck KGaA

14.3.5.    Nippon Fine Chemical Co., Ltd.

14.3.6.    Oriental Aromatics Limited

14.3.7.    Prinova Group LLC

14.3.8.    Rochem International, Inc.

14.3.9.    Saptagir Camphor Limited

14.3.10.    Spectrum Chemical Mfg. Corp.

15.    Acronyms